On 31 January the NHS announced the approval CASGEVY, the first CRISPR gene therapy treatment for sickle cell disease. It will be offered at specialist NHS centres to treat patients who experience ...

Over the last few months, there have been multiple reports on new treatments for sickle cell disease. In this feature, we highlight the biggest updates in this field and think about what the future ...

That's exactly what you will be able to learn as Scaler School of Technology and eGov Foundation, a non-profit organisation founded by Nandan Nilekani and Srikanth Nadhamuni, join hands to ...

Today, CASGEVY is approved for use in patients with sickle cell disease in the United States and multiple countries in Europe and the Middle East. “It’s an amazing gift to have been able to ...

People with sickle cell disease are immunocompromised, which means they have an increased risk of infection. For this reason, immunizations are an important part of complete sickle cell care. This ...

The National Academies of Sciences, Engineering, and Medicine Committee on Sickle Cell Disease in Social Security Disability Evaluations is inviting people with sickle cell disease (SCD) and ...

A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England. About 50 people a year with the inherited blood disorder are likely to ...